Which antibiotics show high resistance for Gonorrhea in Kenya?
Gonorrhea is a common sexually transmitted infection caused by the bacteria Neisseria gonorrhoeae. In some regions, including parts of East Africa, these bacteria have developed significant resistance to several types of antibiotics used to treat the infection.
What the research says
A meta-analysis of data from 2019 to 2024 found that Neisseria gonorrhoeae has a prevalence rate of 22.5% in Kenya 2. This study identified very high resistance rates for specific antibiotics: tetracycline showed 98.0% resistance, ciprofloxacin showed 96.7% resistance, and penicillin showed 94.7% resistance 2.
Other studies have explored the genetic reasons for these resistances in Kenya. Research on isolates from the country found that many strains carry specific genes (such as TetM and TEM) that allow them to resist tetracycline and penicillin 5. Additionally, research into fluoroquinolones—a class of antibiotics that includes ciprofloxacin—showed high resistance rates across several African countries, including Kenya 6. While these drugs show high resistance, other antibiotics like azithromycin, cefixime, and ceftriaxone currently show much lower resistance rates in the region 26.
What to ask your doctor
- Which specific antibiotics are currently most effective for treating gonorrhea in this region?
- Are there local trends regarding antibiotic resistance for Neisseria gonorrhoeae?
- How do current treatment guidelines account for high resistance to ciprofloxacin and tetracycline?
- What is the standard follow-up protocol if a partner also tests positive?
This question is drawn from common patient questions about Infectious Disease and answered using cited medical research. We do not provide individualized advice.